Baseline Characteristics of All Patients Randomized in a Phase IIb Trial of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary Hypertension

Behr, J.Nathan, S. D.Harari, S.Wuyts, W.Bishop, N. MogulkocBouros, D. E.Antoniou, K.Guiot, J.Kramer, M.Kirchgaessler, K.Bengus, M.Gilberg, F.Wells, A. U.2019-10-272019-10-2720191073-449X1535-4970https://hdl.handle.net/11454/29496eninfo:eu-repo/semantics/openAccessBaseline Characteristics of All Patients Randomized in a Phase IIb Trial of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis and Risk of Pulmonary HypertensionConference Object199WOS:000466771105220Q1